TREK-1 isoforms generated by alternative translation initiation display different susceptibility to the antidepressant fluoxetine

被引:20
作者
Eckert, Michaela [1 ]
Egenberger, Brigitte [2 ]
Doering, Frank [1 ]
Wischmeyer, Erhard [1 ]
机构
[1] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany
[2] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany
关键词
K(2)P channels; ATI isoforms; Cellular excitability; Background current; Antidepressants; SSRI; DOMAIN POTASSIUM-CHANNEL; BACKGROUND K+ CHANNEL; DEPRESSION; TRAAK; ANESTHETICS; TASK-1; GENE;
D O I
10.1016/j.neuropharm.2011.06.020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Two-pore-domain K(+) (K(2)P) channels are highly expressed in neurons and cardiac myocytes. In this study we investigated the potency of the antidepressant fluoxetine to inhibit brain and cardiac K(2)P channels, TREK-1, TASK-1 and THIK-1. Maximal sensitivity was detected for TREK-1, which was inhibited by 77% when expressed in HEK-293 cells and Xenopus oocytes. Alternative translation initiation (ATI) generates two different protein products from a single transcript of TREK-1. Electrophysiological analysis of two polypeptides engineered by mutagenesis (TREK-1[M53I], TREK-1[Delta N52]) revealed reduced current amplitude and K(+) selectivity of the truncated TREK-1 isoform. The sensitivity of TREK-1[Delta N52] to fluoxetine decreased by 70%, indicating that the first 52 amino acids are essential for TREK-1 sensitivity to this drug. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:918 / 923
页数:6
相关论文
共 30 条
[1]  
Choi JS, 1999, J PHARMACOL EXP THER, V291, P1
[2]   Reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats [J].
Cornelisse, L. N. ;
Van der Harst, J. E. ;
Lodder, J. C. ;
Baarendse, P. J. J. ;
Timmerman, A. J. ;
Mansvelder, H. D. ;
Spruijt, B. M. ;
Brussaard, A. B. .
JOURNAL OF NEUROPHYSIOLOGY, 2007, 98 (01) :196-204
[3]   TASK, a human background K+ channel to sense external pH variations near physiological pH [J].
Duprat, F ;
Lesage, F ;
Fink, M ;
Reyes, R ;
Heurteaux, C ;
Lazdunski, M .
EMBO JOURNAL, 1997, 16 (17) :5464-5471
[4]   Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel [J].
Fink, M ;
Duprat, F ;
Lesage, F ;
Reyes, R ;
Romey, G ;
Heurteaux, C ;
Lazdunski, M .
EMBO JOURNAL, 1996, 15 (24) :6854-6862
[5]   Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype [J].
Heurteaux, Catherine ;
Lucas, Guillaume ;
Guy, Nicolas ;
El Yacoubi, Malika ;
Thummler, Susanne ;
Peng, Xiao-Dong ;
Noble, Florence ;
Blondeau, Nicolas ;
Widmann, Catherine ;
Borsotto, Marc ;
Gobbi, Gabriella ;
Vaugeois, Jean-Marie ;
Debonnel, Guy ;
Lazdunski, Michel .
NATURE NEUROSCIENCE, 2006, 9 (09) :1134-1141
[6]   Cardiovascular changes associated with venlafaxine in the treatment of late-life depression [J].
Johnson, Ellyn M. ;
Whyte, Ellen ;
Mulsant, Benoit H. ;
Pollock, Bruce G. ;
Weber, Elizabeth ;
Begley, Amy E. ;
Reynolds, Charles F. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (09) :796-802
[7]   Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine [J].
Kennard, LE ;
Chumbley, JR ;
Ranatunga, KM ;
Armstrong, SJ ;
Veale, EL ;
Mathie, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (06) :821-829
[8]   Polyunsaturated fatty acids are potent neuroprotectors [J].
Lauritzen, I ;
Blondeau, N ;
Heurteaux, C ;
Widmann, C ;
Romey, G ;
Lazdunski, M .
EMBO JOURNAL, 2000, 19 (08) :1784-1793
[9]   Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment [J].
Liou, Ying-Jay ;
Chen, Tai-Jui ;
Tsai, Shih-Jen ;
Yu, Younger W-Y ;
Cheng, Chih-Ya ;
Hong, Chen-Jee .
PHARMACOGENETICS AND GENOMICS, 2009, 19 (10) :735-741
[10]   TREK-1 is a heat-activated background K+ channel [J].
Maingret, F ;
Lauritzen, I ;
Patel, AJ ;
Heurteaux, C ;
Reyes, R ;
Lesage, F ;
Lazdunski, M ;
Honoré, E .
EMBO JOURNAL, 2000, 19 (11) :2483-2491